BKinase Inhibitor Chemistry icon  

Eighth Annual

Kinase Inhibitor Chemistry

Emerging Approaches for the Discovery and Design of Kinase Inhibitors

April 25-26, 2017


Over the past decade, kinase drug discovery has resulted in the rapid development of a new generation of anti-cancer drugs. Despite the hundreds of kinase inhibitors currently in discovery, preclinical, and clinical phases, a relatively small subset of the kinome has been thoroughly explored with selective small molecule inhibitors. Kinase inhibitor discovery remains a very active area as developers are exploring more deeply into the human kinome, designing immune-modulatory agents as single or combination therapies, tackling chronic disease indications such as inflammation and CNS disorders, as well as effectively harnessing allosteric modulators and covalently binding compounds.

Cambridge Healthtech Institute’s Eighth Annual Kinase Inhibitor Chemistry conference will once again bring together academic and industry leaders to network, collaborate and discuss advances in kinase discovery.

Topics will include, but are not limited to:

  • Fragment and Structure-Based Design
  • Chemical Biology
  • In silico Modeling
  • Macrocycle Inhibitors
  • Covalent Inhibitors
  • Allosteric Modulators
  • Lead Optimization
  • Preclinical Studies

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is October 7, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

We hope you can join us for this day-and-a-half conference (one of four parallel tracks) that is in the second half of our larger Drug Discovery Chemistry event. Attending this meeting enables you to also hop to concurrent meeting tracks to hear other presentations of interest.

For more details on the conference, please contact:
Kip Harry
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5454
Email: kharry@healthtech.com

For partnering and sponsorship information, please contact:
Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: cbenton@healthtech.com